
Jonathan DeCourcey is a Director and BTIG Cannabis Analyst. Mr. DeCourcey’s cannabis coverage features individual company coverage as well as analysis of the broader cannabis eco-system. Prior to BTIG, Mr. DeCourcey was a Director of Equity Research at Viridian Capital Advisors, where he launched coverage of the firm’s equity research product. Mr. DeCourcey’s research was regularly featured and quoted in financial and traditional media publications and specifically highlighted under followed companies and themes in the industry. Previously, Mr. DeCourcey covered the US Cannabis industry at Canaccord Genuity and before as an associate equity analyst at GW&K Investment Management. He earned a BS from Babson College and an MBA from Boston College.
BackCoverage Area
Company | Ticker |
---|---|
Cresco Labs | CL-CNQ |
Curaleaf Holdings | CURA-CNQ |
Green Thumb Industries | GTII-CNQ |
Trulieve Cannabis Corp. | TRUL-CNQ |
Verano Holdings Corp. | VRNO-CNQ |
Ayr Wellness | AYR.A-CNQ |
4Front Ventures | FFNT-CA |
Ascend Wellness | AAWH |
Cansortium | TIUM.USD-CA |
Jushi | JUSH-CA |
MariMed | MRMD |
Schwazze | SHWZ |
Glass House Brands | GLASF-US |